Literature DB >> 25025366

Glandular neoplasms of the urachus: a report of 55 cases emphasizing mucinous cystic tumors with proposed classification.

Mahul B Amin1, Steven C Smith, John N Eble, Priya Rao, William W L Choi, Pheroze Tamboli, Robert H Young.   

Abstract

Published experience remains limited for glandular neoplasms of the urachus, especially mucinous cystic tumors. We reviewed 55 glandular urachal neoplasms to evaluate their clinical features and histopathologic spectrum and to devise a classification system for the mucinous cystic forms. Within the 55 cases studied, we observed 2 groups with differing clinical, gross, and histopathologic features. The first group, invasive, noncystic adenocarcinomas (n=24), had clinicopathologic features in accord with the known spectrum of urachal adenocarcinoma (mean age 50 y, female:male ratio 1.7, with recurrence or death from disease in 9/16 cases over a 45 mo mean follow-up). The second group, mucinous cystic tumors (n=31), morphologically resembled mucinous cystic tumors of the ovary and appeared classifiable by the same approach (mean age 47 y, female:male ratio 1.4) and included mucinous cystadenoma (n=4), mucinous cystic tumor of low malignant potential (n=22, including 2 cases with intraepithelial carcinoma), and mucinous cystadenocarcinoma with microscopic (n=4) or frank invasion (n=1). Follow-up information was available for 13 patients with mucinous cystic tumors (mean 41 mo); we observed no local recurrence or distant metastasis. This experience suggests that there is a distinct group of glandular, cystic tumors of the urachus that is classifiable in a manner similar to ovarian neoplasms and that has a favorable prognosis after complete excision. As with cystic neoplasms of other organs, rigorous sampling is recommended to identify potentially small foci of carcinoma that could be missed by inadequate sampling. Accordingly, classification based on methods other than complete surgical excision may be hazardous.

Entities:  

Mesh:

Year:  2014        PMID: 25025366     DOI: 10.1097/PAS.0000000000000250

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  12 in total

1.  [Urachal Cancer: an update of current molecular findings].

Authors:  H Reis; F Mairinger; S Ting; N Nagy; K E Witzke; M Kohl; B Sitek; C Niedworok; B Hadaschik; P Nyirády; T Szarvas
Journal:  Pathologe       Date:  2019-12       Impact factor: 1.011

2.  Dataset for the reporting of carcinoma of the bladder-cystectomy, cystoprostatectomy and diverticulectomy specimens: recommendations from the International Collaboration on Cancer Reporting (ICCR).

Authors:  E Compérat; J R Srigley; F Brimo; B Delahunt; M Koch; A Lopez-Beltran; V Reuter; H Samaratunga; J H Shanks; T Tsuzuki; T van der Kwast; M Varma; F Webster; D Grignon
Journal:  Virchows Arch       Date:  2020-01-08       Impact factor: 4.064

3.  Urachal carcinoma: a pathologic and clinical study of 46 cases.

Authors:  Jasreman Dhillon; Yu Liang; Ashish M Kamat; Arlene Siefker-Radtke; Colin P Dinney; Bogdan Czerniak; Charles C Guo
Journal:  Hum Pathol       Date:  2015-08-12       Impact factor: 3.466

4.  Mucinous cystic tumour of low malignant potential presenting in a patient with prior non-seminatous germ cell tumour.

Authors:  Daljeet Chahal; Mildred Martens; John Kinahan
Journal:  Can Urol Assoc J       Date:  2015-10-13       Impact factor: 1.862

5.  Primary signet-ring cell carcinoma of the urinary bladder.

Authors:  Nirmalya Benerjee; Kalpesh Parmar; Kim Vaiphei
Journal:  Autops Case Rep       Date:  2021-04-22

6.  Mucosal urinary secretion revealing adenocarcinoma of urachus.

Authors:  Issam Jandou; Adnan Ettanji; Ettaouil Mohammed; Amine Moataz; Dakir Mohammed; Adil Debbagh; Rachid Aboutaieb
Journal:  Ann Med Surg (Lond)       Date:  2021-04-21

7.  Incidental Finding of a Rare Urachal Pathology: Urachal Mucinous Cystic Tumour of Low Malignant Potential.

Authors:  Luke L Wang; Heath Liddell; Sharman Tan Tanny; Briony Norris; Sree Appu; David Pan
Journal:  Case Rep Urol       Date:  2016-01-03

Review 8.  Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder: A Comprehensive Review Supplemented by Own Data.

Authors:  Henning Reis; Ulrich Krafft; Christian Niedworok; Orsolya Módos; Thomas Herold; Mark Behrendt; Hikmat Al-Ahmadie; Boris Hadaschik; Peter Nyirady; Tibor Szarvas
Journal:  Dis Markers       Date:  2018-03-12       Impact factor: 3.434

9.  Prevalence of APC and PTEN Alterations in Urachal Cancer.

Authors:  Nikolett Nagy; Henning Reis; Boris Hadaschik; Christian Niedworok; Orsolya Módos; Attila Szendrői; Krisztina Bíró; Thomas Hager; Thomas Herold; Jason Ablat; Peter C Black; Krzysztof Okon; Yuri Tolkach; Anita Csizmarik; Csilla Oláh; David Keresztes; Felix Bremmer; Nadine T Gaisa; Joerg Kriegsmann; Ilona Kovalszky; András Kiss; József Tímár; Marcell A Szász; Michael Rink; Margit Fisch; Péter Nyirády; Tibor Szarvas
Journal:  Pathol Oncol Res       Date:  2020-08-04       Impact factor: 3.201

10.  Anterior wall adenocarcinoma of bladder with similar clinicopathological and prognostic characteristics as common bladder carcinomas should not be treated as or classified into urachal adenocarcinomas.

Authors:  Yu-Wen Zhou; Yi-Xiu Long; Kun Song; Li-Bo Liang; Ke Cheng; Ye Chen; Ji-Yan Liu
Journal:  Cancer Med       Date:  2021-07-18       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.